Clinical Trials In Ontario
Discover hundreds of clinical trials in Ontario.
Search clinical trials in Ontario by city, condition or phase.
PREPARE: "Prediabetes Research and Education Promoting Activity & Responsible Eating"
Sponsor:
Brescia University College
Location:
Code:
NCT01396772
Conditions
Prediabetes
Eligibility Criteria
Sex: All
Age: 30+
Healthy Volunteers: Not accepted
Interventions
PREPARE education program
standard of care presentation
Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
Sponsor:
InSightec
Location:
Code:
NCT05383872
Conditions
Glioblastoma
Glioma
Liquid Biopsy
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Focused Ultrasound (Exablate Model 4000)
Evaluating a Virtual Stepped Care Portal in Youth Awaiting Tertiary Chronic Pain Care: An Implementation-Effectiveness Hybrid Type III Study
Sponsor:
The Hospital for Sick Children
Location:
Code:
NCT05894772
Conditions
Chronic Pain
Eligibility Criteria
Sex: All
Age: 12 - 18
Healthy Volunteers: Not accepted
Interventions
Power over Pain Portal
Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Sponsor:
Adaptimmune
Location:
Code:
NCT04044768
Conditions
Synovial Sarcoma
Myxoid Liposarcoma
Eligibility Criteria
Sex: All
Age: 10 - 70+
Healthy Volunteers: Not accepted
Interventions
afamitresgene autoleucel (previously ADP-A2M4)
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
Sponsor:
University of Pennsylvania
Location:
Code:
NCT05446272
Conditions
Extubation Failure
Bronchopulmonary Dysplasia
Death
Eligibility Criteria
Sex: All
Age: 0 - 9
Healthy Volunteers: Not accepted
Interventions
NIV-NAVA
NS-NIPPV
MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)
Sponsor:
The Cleveland Clinic
Location:
Code:
NCT04578392
Conditions
Crohn Disease
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
high ligation of ileocolic artery
mesenteric sparing
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors
Sponsor:
Loxo Oncology, Inc.
Location:
Code:
NCT03899792
Conditions
Medullary Thyroid Cancer
Infantile Myofibromatosis
Infantile Fibrosarcoma
Papillary Thyroid Cancer
Soft Tissue Sarcoma
Eligibility Criteria
Sex: All
Age: 6 - 21
Healthy Volunteers: Not accepted
Interventions
LOXO-292
A Beta-only IL-2 ImmunoTherapY Study
Sponsor:
Medicenna Therapeutics, Inc.
Location:
Code:
NCT05086692
Conditions
Advanced Solid Tumor
Unresectable Solid Tumor
Clear Cell Renal Cell Carcinoma
Triple Negative Breast Cancer
Non-Small Cell Lung Cancer Squamous
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
MDNA11
Pembrolizumab (KEYTRUDA®)
A Study of NVL-520 in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Sponsor:
Nuvalent Inc.
Location:
Code:
NCT05118789
Conditions
Locally Advanced Solid Tumor
Metastatic Solid Tumor
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
NVL-520